Introduction Several studies have investigated the impact of circulating complement-
activating anti-human leukocyte antigen donor-specific antibodies (anti-HLA DSAs) on …

Abstract The Sensitization in Transplantation: Assessment of Risk workgroup is a
collaborative effort of the American Society of Transplantation and the American Society of …

Kidney transplantation is a life-saving strategy for patients with end-stage renal diseases.
Despite the advances in surgical techniques and immunosuppressive agents, the long-term …

Background Serum procalcitonin (PCT) and C-reactive protein (CRP) are biomarkers of
infection. In patients with hematologic disorders with or without hematopoietic stem cell …

In kidney transplantation (KT), overcoming donor shortage is particularly challenging in
patients with preexisting donor-specific antibodies (DSAs) against human leukocyte antigen …

Background Complement-binding donor-specific human leukocyte antigen (HLA) antibodies
in kidney recipients have been associated with a higher risk of allograft rejection and loss …

We investigated whether HLA class II eplet mismatch was related to dnDSA development
and analyzed its combined impact with tacrolimus levels for kidney transplantation …

Antibody-mediated rejection (AMR) is the leading cause of graft failure. While donor-specific
antibodies (DSAs) are associated with a higher risk of AMR, not all patients with DSAs …

Donor‐specific antibody (DSA) is an independent risk factor for antibody‐mediated rejection
(ABMR) and graft loss. The C1q assay differentiates complement from non‐complement …

Ischaemia/reperfusion injury (IRI) is an inevitable and damaging consequence of the
process of kidney transplantation, ultimately leading to delayed graft function and increased …